89bio, Inc. (ETNB) Net Cash Provided by (Used in) Financing Activities USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
89bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2020 to 2024.
  • 89bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $21 M, a 93.5% decline year-over-year.
  • 89bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $513 M, a 335% increase from 2022.
  • 89bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $118 M, a 394% increase from 2021.
  • 89bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $23.9 M, a 84.9% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $21 M -$301 M -93.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $322 M +$322 M +1109052% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $29 K* -$187 K -86.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 $216 K +$207 K +2300% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $9 K* Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.